ZNF568 inhibitors pertain to a class of chemical compounds designed to interact with a specific type of zinc finger protein known as ZNF568. Zinc finger proteins are a family of proteins characterized by the presence of zinc finger motifs, which are small, functional domains stabilized by one or more zinc ions. These domains enable the proteins to bind to DNA, RNA, or other proteins, typically playing crucial roles in transcriptional regulation, DNA recognition, and the coordination of various cellular processes. ZNF568 is one such protein that has been identified to have distinct biological functions within this broad family. Inhibitors targeting ZNF568 are therefore molecules that can bind to this protein and modulate its activity.
The development of ZNF568 inhibitors requires a profound understanding of the protein's structure and function at the molecular level. These inhibitors are typically small molecules that can specifically bind to the ZNF568 protein, thereby altering its interaction with other biomolecules or its ability to bind to specific nucleic acid sequences. The design of such inhibitors often involves the identification of key binding sites on the protein that are essential for its activity. Researchers may use a variety of techniques, including computational modeling, X-ray crystallography, and nuclear magnetic resonance (NMR) spectroscopy, to map the three-dimensional structure of ZNF568 and to understand how inhibitors can effectively bind to these sites. By precisely targeting these critical areas, ZNF568 inhibitors can modulate the function of the protein without affecting other zinc finger proteins, which is important given the extensive and diverse roles that these proteins play in cellular function. The specificity and selectivity of these inhibitors are paramount to their design, as they aim to interact with ZNF568 in a way that precisely alters its activity profile within the cell.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This compound may inhibit DNA methyltransferases, potentially leading to the demethylation of gene promoter regions and altered gene expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
As a histone deacetylase inhibitor, it could result in hyperacetylation of histones, affecting chromatin structure and gene expression patterns. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $54.00 | 6 | |
It can bind to GC-rich DNA sequences, blocking transcription factors and polymerases, potentially down-regulating gene expression. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
By intercalating into DNA, this compound can inhibit RNA polymerase and thus block transcription. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
This compound can inhibit eukaryotic protein synthesis by interfering with the translocation step in ribosomes. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
It can bind to mTOR and inhibit its pathway, which is involved in protein synthesis and cell growth regulation. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
As a proteasome inhibitor, it can prevent the degradation of proteins that regulate the cell cycle and transcription factors. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
This PI3K inhibitor can affect the AKT/mTOR pathway, influencing cell survival and protein synthesis. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK, which may alter the activity of transcription factors and affect gene expression. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
It inhibits p38 MAP kinase, which may modulate transcription factor activity and cytokine production. | ||||||